In Bacterial infections S Cef 1000 mg/500 mg Injection contains two different medicines, Ceftriaxone and Sulbactum, that work together to kill the bacteria that cause infections. Ceftriaxone works by stopping the growth of bacteria. Sulbactam reduces resistance and enhances the activity of Ceftriaxone against bacteria. S Cef 1000 mg/500 mg Injection can be used to treat many different bacterial infections such as ear, sinus, throat, lung, urinary tract, skin and soft tissues. This medicine usually makes you feel better within a few days, but you should continue taking it as prescribed even when you feel better to make sure that all bacteria are killed and do not become resistant.
Consuming alcohol with S Cef 1000 mg/500 mg Injection does not cause any harmful side effects.
S Cef 1000 mg/500 mg Injection is generally considered safe to use during pregnancy. Animal studies have shown low or no adverse effects to the developing baby; however, there are limited human studies.
S Cef 1000 mg/500 mg Injection should be used with caution during breastfeeding. Breastfeeding should be held until the treatment of the mother is completed and the drug is eliminated from her body.
S Cef 1000 mg/500 mg Injection may decrease alertness, affect your vision or make you feel sleepy and dizzy. Do not drive if these symptoms occur.
There is limited information available on the use of S Cef 1000 mg/500 mg Injection in patients with kidney disease. Please consult your doctor.
S Cef 1000 mg/500 mg Injection should be used with caution in patients with severe liver disease. Dose adjustment of S Cef 1000 mg/500 mg Injection may be needed. Please consult your doctor. Dose adjustment of S Cef 1000 mg/500 mg Injection is not recommended in patients with mild to moderate liver disease.
If you miss a dose of S Cef 1000 mg/500 mg Injection, please consult your doctor.
FDC Ltd | B-8, MIDC Area, Waluj - 431 136, Dist. Aurangabad, Maharashtra
Marketer/Manufacturer: Abbott || ₹14.5/tablet (25% cheaper)
No customer reviews yet.
FDA approved prescribing information. Levocitrizine; 1995 [revised May 2007]. [Accessed 01 Apr. 2019] (online) Available from: Read More
European Medicne Agency. Revised assessment report: Ambroxol and bromhexine containing medicinal products. 2015. [Accessed 01 Apr. 2019] (online) Available from: Read More
ScienceDirect. Ambroxol. [Accessed 01 Apr. 2019] (online) Available from: Read More
Levocitrizine. Slough, Berkshire: UCB Pharma Limited; 2007 [revised 27 Mar. 2019]. [Accessed 01 Apr. 2019] (online) Available from: Read More
Marketer/Manufacturer: Bioworld Pharma || ₹14.5/tablet (25% cheaper)
Marketer/Manufacturer: Alcare Laboratories Pvt Ltd || ₹14.5/tablet (25% cheaper)
Marketer/Manufacturer: Balsons Pharmaceutical || ₹14.5/tablet (25% cheaper)
Marketer/Manufacturer: Zeeford Life Sciences || ₹14.5/tablet (25% cheaper)
Marketer/Manufacturer: Kosmed Formulations || ₹14.5/tablet (25% cheaper)
Marketer/Manufacturer: World Healthcare Pharma || ₹14.5/tablet (25% cheaper)
Marketer/Manufacturer: Kanraxy Pharma || ₹14.5/tablet (25% cheaper)
Marketer/Manufacturer: Adroit Lifescience Pvt Ltd || ₹14.5/tablet (25% cheaper)
Marketer/Manufacturer: Nilrise Pharmaceuticals Pvt Ltd || ₹14.5/tablet (25% cheaper)
Marketer/Manufacturer: Niya Biotech || ₹14.5/tablet (25% cheaper)